MedTrace Logo

Antibiotic Prophylaxis for Transrectal Prostate Biopsy-Ciprofloxacin vs. Trimethoprim/Sulfamethoxazole

NCT02734732 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 2800

Last updated 2019-05-15

No results posted yet for this study

Summary

This study will examine if a single dose of Ciprofloxacin and Trimethoprim/Sulfamethoxazole are equivalent for prophylaxis immediately prior to prostate biopsy, when a patient has a suspected prostate cancer.

Conditions

  • Prostate Infection

Interventions

DRUG

Trimethoprim/Sulfamethoxazole

DRUG

Ciprofloxacin

Sponsors & Collaborators

  • Umeå University

    lead OTHER

Principal Investigators

  • Johan Styrke, M.D, Ph.D · Umeå University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2020-04-30
Completion
2020-05-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02734732 on ClinicalTrials.gov